Brain-computer interface (BCI) developer Science Corporation today said it submitted its Prima retinal implant for CE mark ...

Ocular Therapeutix is making sure its corporate vision is 20/20 as it looks forward to phase 3 data on its eye disease drug candidate Axpaxli. | Ocular Therapeutix is making sure its corporate vision ...

Glaukos (NYSE:GKOS) announced that it received EU MDR certification for its iStent Infinite, along with several other ...

Remedy Medical Properties acquired the Dupont Office Center in Bloomington for $10.9M, marking its second Twin Cities medical ...

The global Ophthalmology Drugs Market , valued at US$18.34 billion in 2024 stood at US$19.52 billion in 2025 and is projected to advance at ...

Jessica Chaikof says research into gene therapies could someday save her eyesight. But she worries cuts to federal research ...

The global Diabetic Retinopathy Market is estimated to be valued at USD 9,830 million in 2025 and is projected to reach USD ...

The global Ophthalmology Drugs Market , valued at US$18.34 billion in 2024 stood at US$19.52 billion in 2025 and is projected ...

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

Implants are biomedical materials or medical devices intended to replace a missing biological structure, or support or augment the function of an existing one. Examples of implants are prostheses ...